FERRANTE, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 943
EU - Europa 315
AS - Asia 193
AF - Africa 55
SA - Sud America 8
OC - Oceania 1
Totale 1.515
Nazione #
US - Stati Uniti d'America 937
CN - Cina 100
FI - Finlandia 65
IT - Italia 59
NG - Nigeria 54
SG - Singapore 53
DE - Germania 42
IE - Irlanda 39
FR - Francia 21
IN - India 18
MK - Macedonia 17
RU - Federazione Russa 17
SE - Svezia 17
NL - Olanda 11
PH - Filippine 6
BE - Belgio 5
GB - Regno Unito 5
GR - Grecia 5
JP - Giappone 5
AR - Argentina 3
CA - Canada 3
CU - Cuba 3
IL - Israele 3
PE - Perù 3
CH - Svizzera 2
CZ - Repubblica Ceca 2
HK - Hong Kong 2
PL - Polonia 2
RS - Serbia 2
TR - Turchia 2
TW - Taiwan 2
UA - Ucraina 2
AT - Austria 1
AU - Australia 1
BR - Brasile 1
ID - Indonesia 1
RO - Romania 1
SA - Arabia Saudita 1
UG - Uganda 1
VE - Venezuela 1
Totale 1.515
Città #
Chandler 176
Wilmington 111
Shanghai 91
Boardman 90
Helsinki 65
Ashburn 54
Benin City 54
New York 54
San Mateo 51
Dublin 39
Singapore 34
Ann Arbor 28
Milan 26
Lawrence 22
Princeton 22
Leawood 19
Paris 19
Woodbridge 16
Pune 15
Amsterdam 10
Los Angeles 9
Seattle 9
Skopje 9
Phoenix 7
Fairfield 6
Moscow 6
Abbiategrasso 5
Bitola 5
Brussels 5
Falkenstein 5
London 4
Rome 4
Santa Clara 4
St Petersburg 4
Augsburg 3
Buenos Aires 3
Cologno Monzese 3
Frankfurt am Main 3
Havana 3
Lima 3
Munich 3
Olongapo City 3
Prilep 3
Toronto 3
Brno 2
Des Moines 2
Gdansk 2
Hangzhou 2
Houston 2
Kocaeli 2
Las Pinas 2
Lübeck 2
Mykolayiv 2
Pulandian 2
Sale Marasino 2
Taipei 2
The Bronx 2
Turin 2
Venegono Superiore 2
Atlanta 1
Belgrade 1
Berlin 1
Buffalo 1
Cagayan de Oro 1
Cambridge 1
Canberra 1
Central 1
Chicago 1
Clearwater 1
Delhi 1
Dongguan 1
Dundee 1
Florence 1
Gallarate 1
Garden City 1
Gatchina 1
Guangzhou 1
Gunzenhausen 1
Izhevsk 1
Jakarta 1
Monmouth Junction 1
Nizhniy Novgorod 1
Norwalk 1
Novokuznetsk 1
Omsk 1
Perm 1
Queens 1
Redmond 1
Redwood City 1
Riyadh 1
Rozzano 1
San Diego 1
Sindelfingen 1
Tappahannock 1
Tübingen 1
Totale 1.174
Nome #
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study 136
Interleukin-6 Trans-Signaling and Risk of Future Cardiovascular Events: A New Avenue for Atheroprotection? 63
Direct oral anticoagulants in addition to antiplatelet therapy for secondary prevention after acute coronary syndromes: an updated systematic review and meta-analysis 62
Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis. 62
How should I treat a DES restenosis in a graft anastomosis with challenging access and multiple previous coronary interventions? 61
Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19 60
Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: Effects on blood pressure control and mortality 60
Endovascular treatment vs. intravenous thrombolysis alone for ischaemic stroke: a meta-analysis of randomised controlled trials 58
Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction. 57
Dual Antiplatelet Therapy Continuation Beyond 1 Year After Drug-Eluting Stents: A Meta-Analysis of Randomized Trials 56
ST-Elevation Myocardial Infarction in Patients with COVID-19: Clinical and Angiographic Outcomes 54
Radial Versus Femoral Access for Coronary Interventions Across the Entire Spectrum of Patients With Coronary Artery Disease: A Meta-Analysis of Randomized Trials 54
Meta-Analysis of Randomized Controlled Trials of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Left Main Coronary Artery Disease. 53
Abdominal Aortic Calcification as a Marker of Relationship Between Atherosclerosis and Skeletal Fragility 52
"Fogarty-like" removal of large coronary thrombus 42
Major Bleeding Associated With Very Early Subclinical Valve Thrombosis After Transcatheter Aortic Valve Replacement 40
Clinical Effects of Dual Antiplatelet Therapy or Aspirin Monotherapy after Acute Minor Ischemic Stroke or Transient Ischemic Attack, a Meta-Analysis 38
Mitral Valve Stenosis after Transcatheter Aortic Valve Replacement: Case Report and Review of the Literature 38
Drug-Coated balloons vs drug-eluting stents for the treatment of small coronary artery disease: A meta-analysis of randomized trials 38
Imaging of coronary flow capacity: is there a role for dynamic CT perfusion imaging? 36
Association Between Colchicine Treatment and Clinical Outcomes in Patients with Coronary Artery Disease: Systematic Review and Meta-analysis 35
Distal vs Conventional Radial Access for Coronary Angiography and/or Intervention: A Meta-Analysis of Randomized Trials 35
Impact of myocardial injury on mortality in patients with COVID-19: a meta-analysis 35
Percutaneous Left Atrial Appendage Closure: Rational, Patient Selection, and Preoperative Evaluation. 27
Secondary hyperparathyroidism and thoracic vertebral fractures in heart failure middle-aged patients: a 3-year prospective study 24
P2Y12 vs. aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and Meta-analysis 23
Dual antiplatelet therapy duration after percutaneous coronary intervention with drug-eluting stents: how short can we go? 22
Risk factors for myocardial injury and death in patients with COVID-19: insights from a cohort study with chest computed tomography 22
Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study 22
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in all-comers population. Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry) 20
Percutaneous mitral valve repair for the treatment of acute mitral regurgitation 19
Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: a case-control study in male population from two COVID-19 regional centers of Lombardy, Italy 19
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in patients presenting with acute myocardial infarction: Insight from the ULISSE registry 18
The Placebo Effect on Symptoms, Quality of Life, and Functional Outcomes in Patients With Angina Pectoris: A Meta-analysis of Randomized Placebo-Controlled Trials 18
C-reactive Protein Serum Levels Predict in Stent Restenosis Pattern After Drug Eluting Stent Implantation 18
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in diabetic patients: Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry) 14
Nebivolol versus placebo in patients undergoing anthracyclines (CONTROL Trial): rationale and study design 9
MitraClip Treatment for Severe Mitral Regurgitation Due to Chordae Rupture Following Impella CP Support in a Patient With Severe Aortic Stenosis 8
MicroRNA-132 Inhibition Prevents Myocardial Hypertrophy and Heart Failure in Pigs: Making Sense Out of Antisense 8
One-Month Dual Antiplatelet Therapy After Bioresorbable Polymer Everolimus-Eluting Stents in High Bleeding Risk Patients 7
Rationale and design of the CV-PREVITAL study: an Italian multiple cohort randomised controlled trial investigating innovative digital strategies in primary cardiovascular prevention 6
GLP-1-ra and heart failure-related outcomes in patients with and without history of heart failure: an updated systematic review and meta-analysis 6
The Smokers Health Multiple ACtions (SMAC-1) Trial: Study Design and Results of the Baseline Round 6
Safety of metformin continuation in diabetic patients undergoing invasive coronary angiography: the NO-STOP single arm trial 6
Reply: Distal Transradial Access in Acute Coronary SyndromesShould We Give the First Try? 4
Percutaneous mitral valve repair in acute mitral regurgitation: case report and review of the literature 4
Validation of a Contemporary Acute Kidney Injury Risk Score in Patients With Acute Coronary Syndrome 3
Recommendations for Implementing Lung Cancer Screening with Low-Dose Computed Tomography in Europe 2
One‐stop‐shop totally percutaneous approach for severe aortic and mitral regurgitation in cardiogenic shock 2
Totale 1.562
Categoria #
all - tutte 11.852
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.852


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021239 6 1 3 1 5 61 30 15 50 27 1 39
2021/2022139 3 4 5 26 2 1 4 17 9 3 47 18
2022/2023561 52 17 30 77 85 37 3 42 108 51 47 12
2023/2024566 53 29 77 61 25 71 60 47 18 20 37 68
2024/202557 18 8 7 13 11 0 0 0 0 0 0 0
Totale 1.562